CAMP4 Therapeutics Ownership | Who Owns CAMP4 Therapeutics?


OverviewForecastRevenueFinancialsChart

CAMP4 Therapeutics Ownership Summary


CAMP4 Therapeutics is owned by 3.46% institutional investors, 13.07% insiders, and 83.47% retail investors. Janus henderson group is the largest institutional shareholder, holding 12.15% of CAMP shares. Fidelity Select Biotechnology is the top mutual fund, with 2.55% of its assets in CAMP4 Therapeutics shares.

CAMP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCAMP4 Therapeutics3.46%13.07%83.47%
SectorHealthcare Stocks 35.52%11.86%52.62%
IndustryBiotech Stocks 35.67%11.81%52.52%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Janus henderson group6.31M12.15%$27.88M
5am venture management5.87M11.31%$25.88M
Fmr4.93M9.51%$21.76M
Vanguard group1.67M8.30%$10.26M
Vivo capital4.25M8.18%$18.73M
Balyasny asset management2.63M5.07%$11.61M
Enavate sciences gp2.19M4.22%$9.66M
Ah capital management2.13M4.09%$9.37M
Adage capital partners gp1.96M3.78%$8.65M
Stonepine capital management1.39M2.68%$6.13M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
5am venture management5.87M7.19%$25.88M
Harbourvest partners1.27M5.56%$5.61M
Enavate sciences gp2.19M2.75%$9.66M
Stonepine capital management1.39M2.45%$6.13M
Vivo capital4.25M1.56%$18.73M
Ah capital management2.13M0.73%$9.37M
Silverarc capital management653.59K0.29%$2.88M
Scientech research12.73K0.05%$56.16K
Summittx capital339.52K0.05%$1.50M
683 capital management108.00K0.02%$476.28K

Top Buyers

HolderShares% AssetsChange
Vanguard group1.67M0.00%1.36M
Stonepine capital management1.39M2.45%1.16M
Silverarc capital management653.59K0.29%653.59K
Summittx capital339.52K0.05%339.52K
Susquehanna group, llp336.05K0.00%336.05K

Top Sellers

HolderShares% AssetsChange
Enavate sciences gp2.19M2.75%-844.90K
Franklin resources---635.05K
Ecor1 capital---325.00K
Adage capital partners gp1.96M0.01%-220.90K
Alyeska investment group---200.00K

New Positions

HolderShares% AssetsChangeValue
Summittx capital339.52K0.05%339.52K$1.50M
Susquehanna group, llp336.05K0.00%336.05K$1.48M
Vanguard fiduciary trust195.01K0.00%195.01K$860.01K
Hudson bay capital management lp48.51K0.00%48.51K$213.93K
Hrt financial lp30.75K0.00%30.75K$135.00K

Sold Out

HolderChange
Your advocates ltd., llp-2.00
Eversource wealth advisors-3.00
Sterling capital management-71.00
Nisa investment advisors-101.00
Wells fargo & company/mn-119.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202610-74.36%1,795,202-95.31%30.01%7-70.83%1-88.89%
Dec 31, 202521-25.00%7,426,078-73.68%360.19%1515.38%4-50.00%
Sep 30, 2025273.85%28,010,083139.07%1383.85%13-8-11.11%
Jun 30, 202528-26.32%11,744,55220.46%608.68%14-22.22%10-9.09%
Mar 31, 2025398.33%12,677,518-1.37%342.84%18-50.00%11-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Select Biotechnology1.33M2.55%-
Vanguard Total Stock Mkt Idx Inv1.14M2.19%-
Fidelity Growth Compy Commingled Pl S548.32K1.06%718.00
Fidelity Growth Company Fund400.07K0.77%-
Vanguard Institutional Extnd Mkt Idx Tr358.47K0.69%-
Victory Science & Technology226.60K0.44%-1.20K
Fidelity Extended Market Index170.29K0.33%19.44K
Fidelity Growth Company K6110.22K0.21%-718.00
Fidelity Series Growth Company89.42K0.17%-
iShares Micro-Cap ETF73.29K0.14%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 11, 20255AM Partners VI, LLC-Buy$4.50M
Sep 11, 2025Polaris Management Co. VII, L.L.C.-Buy$130.77K
Sep 11, 2025Polaris Management Co. VII, L.L.C.-Buy$1.87M
Sep 11, 2025Nashat Amir Buy$130.77K
Sep 11, 2025Nashat Amir Buy$1.87M

Insider Transactions Trends


DateBuySell
2026 Q2--
2025 Q4--
2025 Q39-
2025 Q2--
2024 Q2-1

CAMP Ownership FAQ


Who Owns CAMP4 Therapeutics?

CAMP4 Therapeutics shareholders are primarily institutional investors at 3.46%, followed by 13.07% insiders and 83.47% retail investors. The average institutional ownership in CAMP4 Therapeutics's industry, Biotech Stocks , is 35.67%, which CAMP4 Therapeutics falls below.

Who owns the most shares of CAMP4 Therapeutics?

CAMP4 Therapeutics’s largest shareholders are Janus henderson group (6.31M shares, 12.15%), 5am venture management (5.87M shares, 11.31%), and Fmr (4.93M shares, 9.51%). Together, they hold 32.97% of CAMP4 Therapeutics’s total shares outstanding.

Does Blackrock own CAMP4 Therapeutics?

BlackRock is not among the top 10 institutional shareholders of CAMP4 Therapeutics.

Who is CAMP4 Therapeutics’s biggest shareholder by percentage of total assets invested?

5am venture management is CAMP4 Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.19% of its assets in 5.87M CAMP4 Therapeutics shares, valued at 25.88M$.

Who is the top mutual fund holder of CAMP4 Therapeutics shares?

Fidelity Select Biotechnology is the top mutual fund holder of CAMP4 Therapeutics shares, with 2.55% of its total shares outstanding invested in 1.33M CAMP4 Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools